WILSON TROY EDWARD
Director
Sale 10b5-1
- Shares
- 5,000
- Price
- $9.10
- Value
- $45,500
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•19 filings
PBYI
PUMA BIOTECHNOLOGY, INC.
Net sales of $612.5K over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$612,494
0 buyers · 2 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,115,741
10 distinct insiders
Highlighted alerts
1
16 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get PBYI insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PBYI overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
32
Raw transactions
Everything returned by the filing
17
Voluntary view
P/S trades after deterministic checks
15
Administrative noise
Stored, never alerted
23
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 50,000
- Price
- $2.93
- Footnotes
- 3
Adoption date of referenced 10b5-1(c) plan is: 06-15-2026 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.2, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Stock Option is fully vested.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Cesano Alessandra
Director
Sale 10b5-1
- Shares
- 62,150
- Price
- $9.12
- Value
- $566,994
AUERBACH ALAN H
President and CEO
Sale 10b5-1
- Shares
- 44,058
- Price
- $8.26
- Value
- $364,051
HUNT DOUGLAS M
See Remarks
Sale 10b5-1
- Shares
- 8,460
- Price
- $8.26
- Value
- $69,905
NOUGUES MAXIMO F
Chief Financial Officer
Sale 10b5-1
- Shares
- 9,386
- Price
- $8.26
- Value
- $77,557
WILSON TROY EDWARD
Director
Sale 10b5-1
- Shares
- 10,800
- Price
- $7.20
- Value
- $77,748
Stuglik Brian M
Director
Sale 10b5-1
- Shares
- 8,100
- Price
- $7.20
- Value
- $58,311
Senderowicz Adrian
Director
Sale 10b5-1
- Shares
- 27,000
- Price
- $7.20
- Value
- $194,311
MOYES JAY M
Director
Sale 10b5-1
- Shares
- 22,000
- Price
- $7.22
- Value
- $158,796
Dorval Allison
Director
Sale 10b5-1
- Shares
- 11,610
- Price
- $7.20
- Value
- $83,579
AUERBACH ALAN H
President and CEO
Sale 10b5-1
- Shares
- 18,012
- Price
- $5.88
- Value
- $105,893
HUNT DOUGLAS M
See Remarks
Sale 10b5-1
- Shares
- 5,014
- Price
- $5.88
- Value
- $29,477
NOUGUES MAXIMO F
Chief Financial Officer
Sale 10b5-1
- Shares
- 6,405
- Price
- $5.88
- Value
- $37,655
AUERBACH ALAN H
President and CEO
Sale 10b5-1
- Shares
- 16,938
- Price
- $5.84
- Value
- $98,986
HUNT DOUGLAS M
See Remarks
Sale 10b5-1
- Shares
- 3,973
- Price
- $5.84
- Value
- $23,218
NOUGUES MAXIMO F
Chief Financial Officer
Sale 10b5-1
- Shares
- 4,540
- Price
- $5.84
- Value
- $26,532
MILLER MICHAEL PATRICK
Director
SaleAlert
- Shares
- 20,000
- Price
- $4.86
- Value
- $97,228
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | WILSON TROY EDWARD Director | Sale | 5,000 | $9.10 | $45,500 | |
| Sep 14, 2026 | Cesano Alessandra Director | Sale | 62,150 | $9.12 | $566,994 | |
| Jul 06, 2026 | AUERBACH ALAN H President and CEO | Sale | 44,058 | $8.26 | $364,051 | |
| Jul 06, 2026 | HUNT DOUGLAS M See Remarks | Sale | 8,460 | $8.26 | $69,905 | |
| Jul 06, 2026 | NOUGUES MAXIMO F Chief Financial Officer | Sale | 9,386 | $8.26 | $77,557 | |
| Jun 12, 2026 | WILSON TROY EDWARD Director | Sale | 10,800 | $7.20 | $77,748 | |
| Jun 12, 2026 | Stuglik Brian M Director | Sale | 8,100 | $7.20 | $58,311 | |
| Jun 12, 2026 | Senderowicz Adrian Director | Sale | 27,000 | $7.20 | $194,311 | |
| Jun 12, 2026 | MOYES JAY M Director | Sale | 22,000 | $7.22 | $158,796 | |
| Jun 12, 2026 | Dorval Allison Director | Sale | 11,610 | $7.20 | $83,579 | |
| Jan 07, 2026 | AUERBACH ALAN H President and CEO | Sale | 18,012 | $5.88 | $105,893 | |
| Jan 07, 2026 | HUNT DOUGLAS M See Remarks | Sale | 5,014 | $5.88 | $29,477 | |
| Jan 07, 2026 | NOUGUES MAXIMO F Chief Financial Officer | Sale | 6,405 | $5.88 | $37,655 | |
| Jan 06, 2026 | AUERBACH ALAN H President and CEO | Sale | 16,938 | $5.84 | $98,986 | |
| Jan 06, 2026 | HUNT DOUGLAS M See Remarks | Sale | 3,973 | $5.84 | $23,218 | |
| Jan 06, 2026 | NOUGUES MAXIMO F Chief Financial Officer | Sale | 4,540 | $5.84 | $26,532 | |
| Nov 11, 2025 | MILLER MICHAEL PATRICK Director | Sale | 20,000 | $4.86 | $97,228 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.